7/103 sources · 3 publishersUpdated Nov 2, 18:57 UTC
Cerebras stock slides as UBS cuts price target and short‑seller report raises chip durability concerns
Cerebras Systems saw its shares tumble after UBS lowered its 12‑month price target to $250 from $330 and a short‑seller report alleged its wafers degrade after 1.5‑2.5 years. The decline comes amid a wave of insider lockup sales and precedes the company’s Q3 earnings scheduled for November 12.
Why it matters
UBS’s target reduction signals reduced near‑term conviction, which may pressure the stock further. The pending release of lockup shares adds supply risk ahead of the earnings report.
Key facts
- 1Q2 revenue grew 74% year over year to $180.1 million. startupfortune.com
- 2Gross profit fell 20% to $25.6 million. startupfortune.com
- 3UBS cut its 12‑month price target to $250 from $330. investing.com
- 4Shares fell 8.3% to $98.50, a 52‑week low. investing.com
- 5CTO Sean Lie sold more than 710,000 shares for roughly $147.6 million. startupfortune.com
- 6Cerebras is scheduled to report its third‑quarter results on November 12. startupfortune.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.